Your session is about to expire
← Back to Search
Counseling for Depression and Suicide Risk
N/A
Recruiting
Led By Sydney S Ey, Ph.D.
Research Sponsored by Oregon Health and Science University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
* OHSU medical residents, fellows, and full-time School of Medicine faculty
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up time of intake to participants' end of treatment or 6 months since last seen
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing whether an anonymous online screening for stress, depression, substance use, and suicidal thoughts will help medical trainees and faculty who are in distress. It is expected that the screening will make them more likely to come for counseling and that their suicide risk factors will be lower after they receive treatment.
Who is the study for?
This trial is for OHSU medical residents, fellows, and full-time School of Medicine faculty who may be experiencing stress, depression, substance use issues, or suicidal thoughts. The goal is to see if anonymous online screening can encourage them to seek in-person counseling.
What is being tested?
The study tests an online interactive screening tool designed to identify distress signs like depression and suicidal thoughts among medical professionals. It aims to determine if this approach increases their likelihood of pursuing further counseling.
What are the potential side effects?
Since the intervention involves counseling without medication or invasive procedures, no direct physical side effects are expected. However, discussing sensitive topics might cause temporary emotional discomfort.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ time of intake to participants' end of treatment or 6 months since last seen
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~time of intake to participants' end of treatment or 6 months since last seen
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Demographics of residents and faculty physicians who seek counseling through in house program
ISP levels of distress seen with medical trainees and faculty
Who responds to treatment--level of distress
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: CounselingExperimental Treatment1 Intervention
in-person counseling through RFWP to distressed respondents on the ISP and patients who seek counseling without completing the ISP
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
counseling
2007
Completed Phase 3
~1580
Find a Location
Who is running the clinical trial?
Oregon Health and Science UniversityLead Sponsor
1,008 Previous Clinical Trials
7,410,189 Total Patients Enrolled
17 Trials studying Depression
3,078 Patients Enrolled for Depression
Sydney S Ey, Ph.D.Principal InvestigatorOregon Health and Science University
Marie V Soller, MDPrincipal InvestigatorOregon Health and Science University